|
|
Vaccine Detail
|
Infanrix/Hib |
| Vaccine Information |
- Vaccine Name: Infanrix/Hib
- Target Pathogen: Bordetella pertussis
- Target Disease: Whooping Cough
- Product Name: Combined diphtheria, tetanus, acellular pertussis (DTPa) and Haemophilus influenza type b vaccine
- Tradename: Infanrix/Hib
- Manufacturer: GlaxoSmithKline
- Vaccine Ontology ID: VO_0010720
- Type: Subunit vaccine
- Status: Licensed
- Location Licensed: Canada
- Host Species for Licensed Use: Human
- Adjuvant:
- Preservative: 2 phenoxy ethanol
- Allergen: Latex in plunger stopper of prefilled syringe
- Immunization Route: Intramuscular injection (i.m.)
- Storage: Refrigerated stored between +2°C and +8°C.
- Approved Age for Licensed Use: 15 months and older
- Description: Products: Proteins + conjugate. Other components: Formaldehyde, Lactose.
|
| Host Response |
|
|
| References |
|
|
|
